GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanmi Pharm Co Ltd (XKRX:128940) » Definitions » Cash Conversion Cycle

Hanmi Pharm Co (XKRX:128940) Cash Conversion Cycle : 180.52 (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Hanmi Pharm Co Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Hanmi Pharm Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 50.58.
Hanmi Pharm Co's Days Inventory for the three months ended in Mar. 2025 was 150.89.
Hanmi Pharm Co's Days Payable for the three months ended in Mar. 2025 was 20.95.
Therefore, Hanmi Pharm Co's Cash Conversion Cycle (CCC) for the three months ended in Mar. 2025 was 180.52.


Hanmi Pharm Co Cash Conversion Cycle Historical Data

The historical data trend for Hanmi Pharm Co's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanmi Pharm Co Cash Conversion Cycle Chart

Hanmi Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 264.35 209.62 183.41 172.08 185.68

Hanmi Pharm Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 157.18 166.06 189.84 200.51 180.52

Competitive Comparison of Hanmi Pharm Co's Cash Conversion Cycle

For the Drug Manufacturers - Specialty & Generic subindustry, Hanmi Pharm Co's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hanmi Pharm Co's Cash Conversion Cycle Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hanmi Pharm Co's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Hanmi Pharm Co's Cash Conversion Cycle falls into.


;
;

Hanmi Pharm Co Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Hanmi Pharm Co's Cash Conversion Cycle for the fiscal year that ended in Dec. 2024 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=49.59+158.63-22.54
=185.68

Hanmi Pharm Co's Cash Conversion Cycle for the quarter that ended in Mar. 2025 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=50.58+150.89-20.95
=180.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hanmi Pharm Co  (XKRX:128940) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Hanmi Pharm Co Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Hanmi Pharm Co's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Hanmi Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
45 Bangi-dong, Songpa, Seoul, Gyeonggi, KOR, 138-724
Hanmi Pharm Co Ltd is a Korea-based company, engaged in manufacturing and marketing of medicines, medical supplies and raw materials for medicines. The company makes strenuous and enthusiastic efforts to develop treatments for diabetes, obesity, cancer, autoimmune and rare disease to keep everyone's health and improve their quality of life. The group distributes its products within Korean market and to overseas markets.

Hanmi Pharm Co Headlines

No Headlines